跳至主要内容
临床试验/EUCTR2009-015090-12-NL
EUCTR2009-015090-12-NL进行中(未招募)不适用

Standard Treatment Or topical doxepin against Pruritusin burn patients - STOP trial

Association of Dutch Burn Centres0 个研究点开始时间: 2013年7月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with healed burns and itch. Patients are divided into four groups i.e.
  • 1) patients with partial thickness wounds, not exceeding 4 months postburn
  • 2) patients with full thickness wounds, not exceeding 4 months postburn
  • 3) patients with partial thickness wounds between 4 months postburn and 3 years postburn
  • 4) patients with full thickness wounds between 4 months postburn and 3 years postburn
  • Itch intensity as assessed by VAS score greater than or equal to 3
  • Patients treated in one of the three Dutch burn centres
  • Patients aged 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 103
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • - Inability to give informed consent by patient or legal representatives
  • - Inability to understand and fill in VAS scores and quality of life/pruritus assessment questionnaires, as judged by the treating physician
  • - (Active) cutaneous or systemic disease causing itch
  • - Any disease or condition which, according to the physician's judgement, is associated with adverse effects using doxepin, that is:
  • Contra-indications Tavegil
  • - hypersensitivity to clemastine or other arylalkylamine antihistamines, or any of the excipients
  • - porphyria
  • Precautions Tavegil:
  • - fructose intolerance
  • - narrow-angle glaucoma
  • - stenosing peptic ulcer
  • - pyloroduodenal obstruction
  • - prostatic hypertrophy with urinary retention and bladder neck obstruction
  • - galactose intolerance, Lapp lactose deficiency or glucose-galactose malabsorption
  • - pregnancy and lactation
  • Contra-indications Xepin:
  • - hypersensitivity to any of its components.
  • Precautions Xepin
  • - glaucoma
  • - a tendency to urinary retention
  • - severe liver disease
  • - severe heart disease (including cardiac arrythmias)
  • - pregnancy and lactation

研究者

发起方
Association of Dutch Burn Centres

相似试验